Skip to main content

and
  1. No Access

    Article

    Discerning the clinical relevance of biomarkers in early stage breast cancer

    Prior data suggest that breast cancer patients accept significant toxicity for small benefit. It is unclear whether personalized estimations of risk or benefit likelihood that could be provided by biomarkers a...

    Tarah J. Ballinger, Nawal Kassem, Fei Shen in Breast Cancer Research and Treatment (2017)